Green financing rules, pressure from climate groups are pushing Western financiers to shun fossil fuels. Read more at ...
It’s that time of year again for tennis enthusiasts to plan their trek and pilgrimage to the hallowed grounds of the 2025 ...
Shares of energy companies rose as natural-gas futures offset another slip for oil futures. Any talks between the U.S. and Russia on a cease-fire in Ukraine are likely to be drawn-out due to Russian ...
COPENHAGEN, Denmark - Genmab A/S (NASDAQ:GMAB), a biotechnology company specializing in pharmaceutical preparations with a market capitalization of $12.2 billion and an impressive 95% gross profit ...
AlphaValue/Baader downgraded BNP Paribas (BNPQY) to Add from Buy with a price target of EUR 88.90, up from EUR 86.50.Maximize Your Portfolio ...
Barclays raised the firm’s price target on BNP Paribas (BNPQY) to EUR 96 from EUR 84 and keeps an Overweight rating on the shares.Maximize Your ...
BNP Paribas consolidated its status as the leading European corporate and investment bank in 2024, as it strives towards ...
Truist Securities reiterated their Buy rating on Genmab A/S (NASDAQ:GMAB) with a steady price target of $50.00. The firm's analysts remain confident in the biotech company's prospects, particularly in ...
Many Wall Street diversity initiatives are being pulled back in the face of opposition from the Trump administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback